Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 18 studies | 50% ± 21% | |
lung | 13 studies | 30% ± 10% | |
peripheral blood | 9 studies | 26% ± 10% | |
eye | 9 studies | 31% ± 15% | |
kidney | 6 studies | 34% ± 10% | |
liver | 6 studies | 35% ± 19% | |
heart | 5 studies | 38% ± 13% | |
bone marrow | 4 studies | 24% ± 9% | |
lymph node | 4 studies | 18% ± 1% | |
adipose | 4 studies | 32% ± 8% | |
breast | 3 studies | 20% ± 4% | |
intestine | 3 studies | 20% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 21933.12 | 2642 / 2642 | 100% | 64.58 | 705 / 705 |
esophagus | 100% | 16124.46 | 1444 / 1445 | 100% | 80.26 | 183 / 183 |
ovary | 100% | 9577.24 | 180 / 180 | 100% | 48.22 | 428 / 430 |
breast | 100% | 17742.90 | 459 / 459 | 99% | 64.23 | 1111 / 1118 |
skin | 100% | 21518.55 | 1809 / 1809 | 99% | 47.33 | 466 / 472 |
lung | 99% | 13094.87 | 575 / 578 | 99% | 52.40 | 1140 / 1155 |
thymus | 100% | 9568.43 | 651 / 653 | 98% | 29.02 | 593 / 605 |
uterus | 100% | 12349.56 | 170 / 170 | 97% | 36.97 | 444 / 459 |
bladder | 100% | 12916.90 | 21 / 21 | 96% | 29.91 | 483 / 504 |
prostate | 100% | 9773.93 | 244 / 245 | 96% | 32.66 | 483 / 502 |
intestine | 100% | 9991.15 | 963 / 966 | 96% | 31.29 | 506 / 527 |
adrenal gland | 100% | 8876.46 | 258 / 258 | 95% | 29.17 | 219 / 230 |
stomach | 97% | 7000.24 | 349 / 359 | 97% | 39.54 | 277 / 286 |
kidney | 100% | 16078.81 | 89 / 89 | 93% | 31.07 | 842 / 901 |
liver | 88% | 4659.76 | 198 / 226 | 84% | 18.66 | 342 / 406 |
pancreas | 59% | 2338.15 | 194 / 328 | 98% | 33.29 | 174 / 178 |
adipose | 100% | 19720.85 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 14252.02 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 18780.13 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 8993.05 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.35 | 1 / 1 |
lymph node | 0% | 0 | 0 / 0 | 97% | 34.46 | 28 / 29 |
heart | 96% | 15562.26 | 829 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 36.95 | 43 / 45 |
peripheral blood | 94% | 11326.85 | 876 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 23.51 | 74 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0140694 | Biological process | non-membrane-bounded organelle assembly |
GO_0010793 | Biological process | regulation of mRNA export from nucleus |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0034260 | Biological process | negative regulation of GTPase activity |
GO_0002028 | Biological process | regulation of sodium ion transport |
GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
GO_0007507 | Biological process | heart development |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_0045050 | Biological process | protein insertion into ER membrane by stop-transfer membrane-anchor sequence |
GO_0007165 | Biological process | signal transduction |
GO_0038116 | Biological process | chemokine (C-C motif) ligand 21 signaling pathway |
GO_0006811 | Biological process | monoatomic ion transport |
GO_0010820 | Biological process | positive regulation of T cell chemotaxis |
GO_0018107 | Biological process | peptidyl-threonine phosphorylation |
GO_0097022 | Biological process | lymphocyte migration into lymph node |
GO_0006884 | Biological process | cell volume homeostasis |
GO_0050852 | Biological process | T cell receptor signaling pathway |
GO_0055075 | Biological process | potassium ion homeostasis |
GO_0034115 | Biological process | negative regulation of heterotypic cell-cell adhesion |
GO_1904062 | Biological process | regulation of monoatomic cation transmembrane transport |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0003084 | Biological process | positive regulation of systemic arterial blood pressure |
GO_0031397 | Biological process | negative regulation of protein ubiquitination |
GO_0048666 | Biological process | neuron development |
GO_0033633 | Biological process | negative regulation of cell-cell adhesion mediated by integrin |
GO_0030644 | Biological process | intracellular chloride ion homeostasis |
GO_0010507 | Biological process | negative regulation of autophagy |
GO_1990869 | Biological process | cellular response to chemokine |
GO_0071474 | Biological process | cellular hyperosmotic response |
GO_0090188 | Biological process | negative regulation of pancreatic juice secretion |
GO_1903490 | Biological process | positive regulation of mitotic cytokinesis |
GO_1903038 | Biological process | negative regulation of leukocyte cell-cell adhesion |
GO_0006468 | Biological process | protein phosphorylation |
GO_1904595 | Biological process | positive regulation of termination of RNA polymerase II transcription |
GO_1902305 | Biological process | regulation of sodium ion transmembrane transport |
GO_0055080 | Biological process | monoatomic cation homeostasis |
GO_0035725 | Biological process | sodium ion transmembrane transport |
GO_1903077 | Biological process | negative regulation of protein localization to plasma membrane |
GO_0072686 | Cellular component | mitotic spindle |
GO_0016020 | Cellular component | membrane |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005829 | Cellular component | cytosol |
GO_0043232 | Cellular component | intracellular non-membrane-bounded organelle |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0004672 | Molecular function | protein kinase activity |
GO_0030295 | Molecular function | protein kinase activator activity |
GO_0019902 | Molecular function | phosphatase binding |
GO_0140693 | Molecular function | molecular condensate scaffold activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | WNK1 |
Protein name | Serine/threonine-protein kinase WNK1 (EC 2.7.11.1) (Erythrocyte 65 kDa protein) (p65) (Kinase deficient protein) (Protein kinase lysine-deficient 1) (Protein kinase with no lysine 1) (hWNK1) non-specific serine/threonine protein kinase (EC 2.7.11.1) Alternative protein WNK1 WNK lysine deficient protein kinase 1 WNK1 protein |
Synonyms | HSN2 KIAA0344 PRKWNK1 KDP |
Description | FUNCTION: Serine/threonine-protein kinase component of the WNK1-SPAK/OSR1 kinase cascade, which acts as a key regulator of blood pressure and regulatory volume increase by promoting ion influx . WNK1 mediates regulatory volume increase in response to hyperosmotic stress by acting as a molecular crowding sensor, which senses cell shrinkage and mediates formation of a membraneless compartment by undergoing liquid-liquid phase separation . The membraneless compartment concentrates WNK1 with its substrates, OXSR1/OSR1 and STK39/SPAK, promoting WNK1-dependent phosphorylation and activation of downstream kinases OXSR1/OSR1 and STK39/SPAK . Following activation, OXSR1/OSR1 and STK39/SPAK catalyze phosphorylation of ion cotransporters SLC12A1/NKCC2, SLC12A2/NKCC1, SLC12A5/KCC2 and SLC12A6/KCC3, regulating their activity . Phosphorylation of Na-K-Cl cotransporters SLC12A2/NKCC1 and SLC12A2/NKCC1 promote their activation and ion influx; simultaneously, phosphorylation of K-Cl cotransporters SLC12A5/KCC2 and SLC12A6/KCC3 inhibit their activity, blocking ion efflux . Also acts as a regulator of angiogenesis in endothelial cells via activation of OXSR1/OSR1 and STK39/SPAK: activation of OXSR1/OSR1 regulates chemotaxis and invasion, while STK39/SPAK regulates endothelial cell proliferation . Also acts independently of the WNK1-SPAK/OSR1 kinase cascade by catalyzing phosphorylation of other substrates, such as SYT2, PCF11 and NEDD4L . Mediates phosphorylation of SYT2, regulating SYT2 association with phospholipids and membrane-binding (By similarity). Regulates mRNA export in the nucleus by mediating phosphorylation of PCF11, thereby decreasing the association between PCF11 and POLR2A/RNA polymerase II and promoting mRNA export to the cytoplasm . Acts as a negative regulator of autophagy . Required for the abscission step during mitosis, independently of the WNK1-SPAK/OSR1 kinase cascade . May also play a role in actin cytoskeletal reorganization . Also acts as a scaffold protein independently of its protein kinase activity: negatively regulates cell membrane localization of various transporters and channels, such as SLC4A4, SLC26A6, SLC26A9, TRPV4 and CFTR (By similarity). Involved in the regulation of epithelial Na(+) channel (ENaC) by promoting activation of SGK1 in a kinase-independent manner: probably acts as a scaffold protein that promotes the recruitment of SGK1 to the mTORC2 complex in response to chloride, leading to mTORC2-dependent phosphorylation and activation of SGK1 . Acts as an assembly factor for the ER membrane protein complex independently of its protein kinase activity: associates with EMC2 in the cytoplasm via its amphipathic alpha-helix, and prevents EMC2 ubiquitination and subsequent degradation, thereby promoting EMC2 stabilization . .; FUNCTION: [Isoform 3]: Kinase-defective isoform specifically expressed in kidney, which acts as a dominant-negative regulator of the longer isoform 1 . Does not directly inhibit WNK4 and has no direct effect on sodium and chloride ion transport (By similarity). Down-regulates sodium-chloride cotransporter activity indirectly by inhibiting isoform 1, it associates with isoform 1 and attenuates its kinase activity (By similarity). In kidney, may play an important role regulating sodium and potassium balance (By similarity). . |
Accessions | ENST00000545285.5 ENST00000535572.5 L8EA38 H0YF81 ENST00000340908.9 [Q9H4A3-5] A5XEH6 ENST00000676347.1 ENST00000574679.1 ENST00000537687.5 [Q9H4A3-6] ENST00000534872.1 F6UYG0 ENST00000315939.11 [Q9H4A3-1] H0YH68 A5XEH8 F5GWT4 ENST00000530271.6 [Q9H4A3-7] ENST00000535698.1 ENST00000675631.1 [Q9H4A3-4] A5XEH9 H0YFP5 ENST00000544559.1 H0YH79 ENST00000447667.2 A5D8Z4 I3L251 A5XEH7 Q9H4A3 A0A6Q8PFM0 |